Floatz logo

Atezolizumab

Clinical Stage IV Merkel Cell Carcinoma AJCC v8

M.D. Anderson Cancer Centermonoclonal_antibodyPhase 2Active
B
60/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
45/ 100
Competitive Position
95/ 100

Competitive context

8 Active assets in the Clinical Stage IV Merkel Cell Carcinoma AJCC v8 cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Mayo Clinic
Phase 1/2CCC
Pembrolizumab
Mayo Clinic
Phase 1/2CCC
Npi-2358
M.D. Anderson Cancer Center
Phase 1/2CCC
Sargramostim
Mayo Clinic
Phase 1/2CCC
Epirubicin
Mayo Clinic
Phase 1/2CCC

View all 10 →

Same molecule, other indications

Atezolizumab is also rated in:

metastatic neoplasmDormant
BB
Indicative ·
71 / 100
View asset →
Stage IV Lung Cancer AJCC v8Dormant
BB
Indicative ·
70 / 100
View asset →
Her2-receptor negative breast cancerDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →